United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

peckforton pharmaceuticals ltd - mesna - solution for injection - 100mg/1ml

Bangladesh - English - DGDA (Directorate General of Drug Administration)

techno drugs ltd. - mesna disulfide - injection - 400 mg/4 ml

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - mesna - film-coated tablet - 400 milligram(s) - detoxifying agents for antineoplastic treatment; mesna

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

baxter healthcare south africa (pty) ltd - mesna a - injection - 400 mg - each 1 ml injection contains mesna a 100 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - imatinib mesilate - tablet - 100mg

Israel - English - Ministry of Health

megapharm ltd - mesna - solution for injection - mesna 400 mg/vial - mesna - prevention of urinary passage toxicity of oxazaphosphorines (ifosfamide ,cyclophosphamide, trofosamide), in particular in high-risk patients with previous radiation therapy in the area of the lesser pelvis, cystitis with previous ifosfamide, cyclophosphamide or trofosamide , urinary passage diseases in anamnesis.

Kenya - English - Pharmacy and Poisons Board

getwell pharmaceuticals ltd 474, udyog vihar, phase-v, gurugram- 122016, - ifosfamide usp and mesna bp - powder for injection - 2gm of sterile ifosfamide usp and mesna bp… - combinations of antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

baxter holding b.v. - mesna - film-coated tablet - 600 milligram(s) - detoxifying agents for antineoplastic treatment; mesna

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - mesna 600mg - film coated tablet - 600 mg - active: mesna 600mg excipient: calcium hydrogen phosphate dihydrate hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose povidone simeticone titanium dioxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide [endoxan] and ifosfamide [holoxan] data sheets).

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - mesna 400mg - tablet - 400 mg - active: mesna 400mg excipient: calcium hydrogen phosphate dihydrate hypromellose lactose monohydrate macrogol 6000 magnesium stearate maize starch microcrystalline cellulose povidone simeticone titanium dioxide - for the reduction and prevention of urinary tract toxicity (haemorrhagic cystitis) of oxazaphosphorines (see adverse effects sections of the cyclophosphamide [endoxan] and ifosfamide [holoxan] data sheets).